# US 2023/0264202 A1 · Digital to biological converter

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0264202 A1
- Document ID: US20230264202A1
- Status: Published application
- Kind: A1
- Application number: 18/129,775
- Filed: 2023-03-31
- Published: 2023-08-24
- Earliest claimed: 2012-08-16
- Assignees: Telesis Bio Inc.
- Applicants: Telesis Bio Inc.
- Inventors: J. Craig Venter; Daniel Gibson; John E. Gill
- Web page: https://patentgrep.com/patent/US20230264202A1

## CPC

- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- A61P 31/16: for influenza or rhinoviruses
- C07K 14/005: from viruses
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 15/1089: {Design, preparation, screening or analysis of libraries using computer algorithms}
- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The present invention provides a system for receiving biological sequence information and activating the synthesis of a biological entity. The system has a receiving unit for receiving a signal encoding biological sequence information transmitted from a transmitting unit. The transmitting unit can be present at a remote location from the receiving unit. The system also has an assembly unit connected to the receiving unit, and the assembly unit assembles the biological entity according to the biological sequence information. Thus, according to the present invention biological sequence information can be digitally transmitted to a remote location and the information converted into a biological entity, for example a protein useful as a vaccine, immediately upon being received by the receiving unit and without further human intervention after preparing the system for receipt of the information. The invention is useful, for example, for rapidly responding to viral and other biological threats that are specific to a particular locale.

## Claims

### Claim 1

A method of synthesizing a functional biological entity comprising:
receiving biological sequence information from a transmitting unit in a system for synthesizing the functional biological entity, the system comprising:
an assembly unit connected to the receiving unit, for assembling the functional biological entity according to the biological sequence information, the assembly unit comprising or connected to vessels containing biological building block molecules and reagents for performing reactions to synthesize the functional biological entity from the biological building block molecules;
wherein the assembly unit is configured to assemble the biological entity in accordance with the biological sequence information; and
synthesizing the functional biological entity in an automated method.

### Claim 2 (depends on 1)

The method of claim 1 wherein the transmitting unit and the receiving unit are computers that are part of a computer network.

### Claim 3 (depends on 1)

The method of claim 1 wherein the biological building blocks are dNTPs or nucleoside phosphoramidites.

### Claim 4 (depends on 3)

The method of claim 3 wherein the system further comprises programming instructions for assembling the dNTPs or nucleoside phosphoramidites into a set of oligonucleotides according to the biological sequence information.

### Claim 5 (depends on 4)

The method of claim 4 wherein the system further comprises programming instructions for assembling the set of oligonucleotides into a DNA molecule.

### Claim 6 (depends on 1)

The method of claim 1 wherein the functional biological entity is a DNA molecule.

### Claim 7

An automated system for the synthesis of a double-stranded DNA molecule according to provided biological sequence information, comprising:
an assembly unit that assembles the double-stranded DNA molecule according to the provided biological sequence information, the assembly unit comprising or connected to vessels containing a plurality of oligonucleotide molecules and containing components that transport reagents within the system and that executes steps in an automated method for synthesizing the double-stranded DNA molecule, wherein the method comprises the assembly of one or more dsDNA molecule(s) by joining the plurality of oligonucleotides, and wherein no human intervention occurs after the method is initiated and until the double-stranded DNA molecule is synthesized; and
the system further comprising a non-transitory computer readable medium containing software programming instructions that direct steps in the assembly unit for the assembly of the plurality of oligonucleotide molecules into the double stranded DNA molecule in the automated method,
wherein the system further comprises a robotic arm configured to transfer the oligonucleotide molecules from the first reaction zone to the second reaction zone, and from the second reaction zone to the third reaction zone, the oligonucleotide molecules successively accumulating in each reaction zone.

### Claim 8 (depends on 7)

The automated system of claim 7 wherein the oligonucleotides are provided to a sub-unit of the assembly unit for amplification of the oligonucleotides by the step of PCR.

### Claim 9 (depends on 7)

The automated system of claim 7 wherein the oligonucleotides are from 40-100 nucleotides in length.

### Claim 10 (depends on 7)

The automated system of claim 7 wherein the system further comprises software programming instructions and reagents directing steps for the transcription of the DNA molecule into an RNA molecule.

### Claim 11 (depends on 10)

The automated system of claim 10 wherein the system further comprises software programming instructions and reagents directing translation of the RNA molecule into a protein molecule.

### Claim 12 (depends on 7)

The system of claim 7 wherein the conditions for a step are established in a reaction zone and a sample is subsequently moved into the reaction zone.

### Claim 13 (depends on 7)

The system of claim 7 further comprising that the software programming instructions direct an RNA transcription step performed in a reaction zone of a reaction container.

### Claim 14 (depends on 7)

The automated system of claim 7 wherein the double stranded DNA molecule is greater than 500 bp in size.

### Claim 15 (depends on 7)

The automated system of claim 7 wherein the software programming instructions comprise instructions for simultaneously assembling the plurality of oligonucleotide molecules into the dsDNA molecule(s).

### Claim 16 (depends on 7)

The automated system of claim 7 wherein the plurality of oligonucleotide molecules are 30-110 nucleotides in length.

### Claim 17 (depends on 7)

The automated system of claim 7 wherein the overlapping oligonucleotides are assembled in an isothermal reaction.

### Claim 18 (depends on 7)

The automated system of claim 7 wherein the plurality of oligonucleotide molecules is assembled into the dsDNA molecule(s) in a simultaneous reaction.

### Claim 19 (depends on 7)

The automated system of claim 7 wherein the overlapping oligonucleotides are assembled in a reaction using an exonuclease and a DNA polymerase.

### Claim 20 (depends on 7)

The automated system of claim 7 wherein the error correction reaction comprises the use of a mismatch endonuclease.
